Flexion Therapeutics

$9.41
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.26 (-2.69%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell FLXN and other stocks, options, and ETFs commission-free!

About FLXN

Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis.

CEO

Michael D. Clayman

Employees

257

Headquarters

Burlington, Massachusetts

Founded

2015

Market Cap

416.20M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.14M

High Today

$9.75

Low Today

$9.20

Open Price

$9.73

Volume

572.23K

52 Week High

$14.39

52 Week Low

$7.52

Analyst Ratings

91%

of 11 ratings

Buy

91%

Hold

Sell

FLXN Earnings

-$1.00

-$0.67

-$0.33

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 6, After Hours